Comparison

GSK-1070916 European Partner

Item no. TMO-T6129-100mg
Manufacturer TargetMol
CASRN 942918-07-2
Amount 100 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 200 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,98
Smiles CCn1cc(c(n1)-c1ccc(NC(=O)N(C)C)cc1)-c1ccnc2[nH]c(cc12)-c1cccc(CN(C)C)c1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias GSK-1070916A,GSK1070916
Shipping Condition Cool pack
Available
Manufacturer - Targets
Tie-2|||FLT|||Apoptosis|||Aurora Kinase|||AMPK
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
507.63
Description
GSK-1070916 (GSK-1070916A) is a reversible and ATP-competitive inhibitor of Aurora B/C with IC50 of 3.5 nM/6.5 nM. It displays >100-fold selectivity against the closely related Aurora A-TPX2 complex. Phase 1.
Pathways
Apoptosis|||PI3K/Akt/mTOR signaling|||Angiogenesis|||Chromatin/Epigenetic|||Tyrosine Kinase/Adaptors|||Cell Cycle/Checkpoint

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close